Goodness Growth Secures Patent on Cannabis-based Moist Snuff Products

Goodness Growth获得大麻湿润鼻烟产品专利

2021-09-02 02:30:10 CFN Media Group

本文共840个字,阅读需3分钟

Goodness Growth Holdings, Inc. (CSE: GDNS; OTCQX: GDNSF), a physician-led, science-focused cannabis company and IP incubator, announced today that the United States Patent and Trademark Office has issued a Notice of Allowance for its subsidiary company Resurgent Biosciences, Inc.’s patent application titled “Cannabis Based Moist Snuff.” This patent covers the product distribution format as well as the method for producing moist snuff from cannabis plants. “The receipt of this patent highlights the quality and strength of innovation from our team at Resurgent Biosciences, and is consistent with our long-term strategy to develop meaningful, protectable intellectual property and simultaneously disrupt the tobacco industry with safer, cannabis-based alternatives,” said Chairman & Chief Executive Officer, Kyle Kingsley, M.D. “We believe cannabis snuff products could have wide appeal to consumers in the future, and we look forward to partnering with organizations who recognize the substantial value these innovations and future generation of products could represent.” Cannabis-based snuff products offer a way to commercialize a new cannabis product form factor in a delivery format that has previously demonstrated consumer appeal in the multibillion-dollar tobacco industry, where moist snuff is the most popular smokeless product category. Resurgent Biosciences and its licensees will be able to monetize future cannabis snuff products and brands by creating new revenue streams in both the retail and wholesale sales channels, thanks to the patented technology. Resurgent’s unique technique will allow the company to create cannabis moist snuff products that will have a faster onset and bioavailability than consumed edibles, but a delayed onset than smoking or vaping cannabis. The moist snuff products can be made with or without cannabinoids, and with different doses of THC, CBD, CBN, and customisable terpene profiles to produce different effects and outcomes for adult users and medicinal patients. Visit https://goodnessgrowth.com/resurgent-biosciences to discover more about Resurgent Biosciences. This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
Goodness Growth Holdings,Inc.(CSE:GDNS;OTCQX:GDNSF)是一家以医生为主导、以科学为重点的大麻公司和知识产权孵化器,它今天宣布,美国专利商标局已经对其子公司Resrentury Biosciences,Inc.题为“基于大麻的潮湿鼻烟”的专利申请发出了许可通知。该专利涵盖了产品分销格式以及从大麻植物中生产潮湿鼻烟的方法。 董事长兼首席执行官凯尔·金斯利医学博士说:“这项专利的获得凸显了我们复兴生物科学团队的创新质量和实力,并符合我们的长期战略,即开发有意义的、可保护的知识产权,同时用更安全的、基于大麻的替代品扰乱烟草行业。”“我们相信大麻鼻烟产品未来可能会对消费者产生广泛的吸引力,我们期待着与认识到这些创新和下一代产品可能代表的巨大价值的组织合作。” 以大麻为基础的鼻烟产品提供了一种将新的大麻产品形式因素商业化的方式,这种交付方式以前曾在价值数十亿美元的烟草行业显示出消费者吸引力,潮湿的鼻烟是最受欢迎的无烟产品类别。由于这项专利技术,复兴生物科学及其被许可人将能够通过在零售和批发销售渠道中创造新的收入来源,使未来的大麻鼻烟产品和品牌货币化。 Resnurgent的独特技术将使该公司能够创造出大麻湿润鼻烟产品,这种产品的起效和生物利用度将比食用食品更快,但比吸烟或吸食大麻的起效时间更晚。湿润的鼻烟产品可以有或不有大麻素,并与不同剂量的四氢大麻酚,CBD,CBN和可定制的萜烯剖面产生不同的效果和结果,为成人用户和病人。访问https://goodnessgrowth.com/restrength-biosciences了解更多关于复兴的生物科学的信息。 本文由CFN Enterprises Inc.(OTCQB:CNFN)发表,该公司是CFN Media的所有者和运营商,CFN Media是行业领先的机构和数字金融媒体网络,致力于新兴的CBD和合法大麻行业。请致电+1(833)420-CNFN了解更多信息。

以上中文文本为机器翻译,存在不同程度偏差和错误;偶尔因源网页结构局限,内容无法一次完整呈现。请理解并参考原站原文阅读。

阅读原文